Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Shieldin complex subunit 2 pseudogene 2 (SHLD2P2) is a non-coding pseudogene corresponding to the parental shieldin complex subunit 2 gene (SHLD2)[1]. Unlike its parental gene, which encodes a protein involved in the DNA double-strand break repair pathway[4], SHLD2P2 does not produce a functional protein and is not considered a target for therapeutic intervention. There is currently no evidence for regulatory function, disease involvement, or drug interaction for SHLD2P2. As a class, pseudogenes may in some cases exert regulatory effects or be involved in genetic or epigenetic disease mechanisms, but no such roles have been described for SHLD2P2[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Shieldin complex subunit 2 pseudogene 2 (SHLD2P2).